Hołubowicz, Rafał
Du, Samuel W. https://orcid.org/0000-0002-9655-3659
Felgner, Jiin
Smidak, Roman
Choi, Elliot H.
Palczewska, Grazyna
Menezes, Carolline Rodrigues
Dong, Zhiqian https://orcid.org/0000-0002-8748-4532
Gao, Fangyuan
Medani, Omar
Yan, Alexander L. https://orcid.org/0000-0002-8594-7994
Hołubowicz, Maria W.
Chen, Paul Z.
Bassetto, Marco
Risaliti, Eleonora
Salom, David https://orcid.org/0000-0002-3208-1509
Workman, J. Noah https://orcid.org/0000-0002-0921-1803
Kiser, Philip D. https://orcid.org/0000-0003-1184-9539
Foik, Andrzej T. https://orcid.org/0000-0003-1110-9223
Lyon, David C.
Newby, Gregory A.
Liu, David R. https://orcid.org/0000-0002-9943-7557
Felgner, Philip L. https://orcid.org/0000-0002-4117-8505
Palczewski, Krzysztof https://orcid.org/0000-0002-0788-545X
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01EY009339, R01EY030873, P30EY034070, P30CA062203)
U.S. Department of Health & Human Services | National Institutes of Health (T32GM008620, F30EY033642)
U.S. Department of Health & Human Services | National Institutes of Health (P30EY034070)
U.S. Department of Health & Human Services | National Institutes of Health (T32GM148383)
U.S. Department of Health & Human Services | National Institutes of Health (R01EY032948, R21NS113264)
U.S. Department of Health & Human Services | National Institutes of Health (R00HL163805)
U.S. Department of Health & Human Services | National Institutes of Health (UG3AI150551, U01AI142756, R35GM118062, RM1HG009490)
U.S. Department of Health & Human Services | National Institutes of Health (75N93022C00054)
Knights Templar Eye Foundation
U.S. Department of Veterans Affairs (I01BX004939)
Narodowe Centrum Nauki (2022/47/B/NZ5/03023, 2020/39/D/NZ4/01881, 2019/34/E/NZ5/00434)
Fundacja na rzecz Nauki Polskiej (FENG.02.01-IP.05-T005/23)
Howard Hughes Medical Institute
United States Department of Defense | Defense Threat Reduction Agency (N66001-21-C-4013)
Article History
Received: 19 December 2023
Accepted: 25 October 2024
First Online: 28 November 2024
Competing interests
: K.P. is a consultant for Polgenix Inc. and AbbVie Inc. and serves on the Scientific Advisory Board of Hyperion Eye Ltd. D.R.L. is a consultant and/or equity owner for Prime Medicine, Beam Therapeutics, Pairwise Plants, Chroma Medicine and Nvelop Therapeutics, companies that use or deliver genome-editing or epigenome-engineering agents. G.A.N. and D.R.L. have filed patent applications on other genome editing technologies through the Broad Institute. The other authors declare no competing interests.